enVVeno Medical Statistics
Total Valuation
enVVeno Medical has a market cap or net worth of $3.87 million. The enterprise value is -$14.20 million.
Important Dates
The last earnings date was Thursday, October 29, 2026, after market close.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
enVVeno Medical has 694,826 shares outstanding. The number of shares has increased by 14.23% in one year.
| Current Share Class | 694,826 |
| Shares Outstanding | 694,826 |
| Shares Change (YoY) | +14.23% |
| Shares Change (QoQ) | +3.43% |
| Owned by Insiders (%) | 2.94% |
| Owned by Institutions (%) | 11.39% |
| Float | 638,255 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.23 |
| P/TBV Ratio | 0.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.35, with a Debt / Equity ratio of 0.02.
| Current Ratio | 7.35 |
| Quick Ratio | 7.13 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -67.11% and return on invested capital (ROIC) is -44.01%.
| Return on Equity (ROE) | -67.11% |
| Return on Assets (ROA) | -60.00% |
| Return on Invested Capital (ROIC) | -44.01% |
| Return on Capital Employed (ROCE) | -99.05% |
| Weighted Average Cost of Capital (WACC) | 10.71% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$471,273 |
| Employee Count | 33 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.11% in the last 52 weeks. The beta is 1.38, so enVVeno Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | -48.11% |
| 50-Day Moving Average | 7.57 |
| 200-Day Moving Average | 9.96 |
| Relative Strength Index (RSI) | 31.33 |
| Average Volume (20 Days) | 26,232 |
Short Selling Information
The latest short interest is 24,103, so 3.47% of the outstanding shares have been sold short.
| Short Interest | 24,103 |
| Short Previous Month | 11,771 |
| Short % of Shares Out | 3.47% |
| Short % of Float | 3.78% |
| Short Ratio (days to cover) | 0.58 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.74M |
| Pretax Income | -15.55M |
| Net Income | -15.55M |
| EBITDA | -16.66M |
| EBIT | -16.74M |
| Earnings Per Share (EPS) | -$23.50 |
Full Income Statement Balance Sheet
The company has $18.47 million in cash and $408,000 in debt, with a net cash position of $18.06 million or $26.00 per share.
| Cash & Cash Equivalents | 18.47M |
| Total Debt | 408,000 |
| Net Cash | 18.06M |
| Net Cash Per Share | $26.00 |
| Equity (Book Value) | 16.90M |
| Book Value Per Share | 24.32 |
| Working Capital | 16.43M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -13.41M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 82,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -13.41M |
| FCF Per Share | -$19.30 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
enVVeno Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -14.23% |
| Shareholder Yield | -14.23% |
| Earnings Yield | -422.31% |
| FCF Yield | -346.44% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on January 20, 2026. It was a reverse split with a ratio of 1:35.
| Last Split Date | Jan 20, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:35 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |